Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs PPH overlap: 43% of top holdings shared

Bottom line

How much do XLV and PPH overlap?

43% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 47.4% of XLV's assets and 55.5% of PPH's. They share a meaningful core but differ in the rest of the portfolio.

XLV holds far more positions (65 vs 26), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVPPH
Weight overlap (top 25)43%
Shared holdings8
Weight in shared holdings47.4%55.5%
Total positions6526
Expense ratio0.08%0.36%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and PPH have in common

Holding% of XLV% of PPHOverlap
Eli Lilly & Co16.51%20.23%16.51%
Johnson & Johnson10.64%4.35%4.35%
AbbVie Inc7.74%4.57%4.57%
Merck & Co Inc5.52%9.85%5.52%
Pfizer Inc2.39%4.51%2.39%
Bristol-Myers Squibb Co2.05%4.47%2.05%
McKesson Corp1.58%4.12%1.58%
Cencora Inc0.96%3.36%0.96%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. UnitedHealth Group Inc — 6.57%
  2. Amgen Inc — 3.40%
  3. Thermo Fisher Scientific Inc — 3.24%
  4. Abbott Laboratories — 2.75%
  5. Gilead Sciences Inc — 2.73%
  6. Intuitive Surgical Inc — 2.45%
  7. CVS Health Corp — 2.30%
  8. Vertex Pharmaceuticals Inc — 2.19%
  9. Danaher Corp — 2.09%
  10. Stryker Corp — 1.89%
  11. Medtronic PLC — 1.75%
  12. Elevance Health Inc — 1.46%
  13. Cigna Group/The — 1.27%
  14. Boston Scientific Corp — 1.10%
  15. Regeneron Pharmaceuticals Inc — 1.08%

Only in PPH

  1. Novartis AG — 10.63%
  2. Novo Nordisk A/S — 5.37%
  3. Gsk Plc — 4.42%
  4. AstraZeneca PLC — 4.33%
  5. Sanofi SA — 4.00%
  6. Haleon PLC — 3.09%
  7. Teva Pharmaceutical Industries Ltd — 3.06%
  8. Takeda Pharmaceutical Co Ltd — 2.87%
  9. Zoetis Inc — 2.10%
  10. Viatris Inc — 1.10%
  11. Jazz Pharmaceuticals PLC — 1.08%
  12. Axsome Therapeutics Inc — 0.77%
  13. Corcept Therapeutics Inc — 0.50%
  14. Elanco Animal Health Inc — 0.35%
  15. State Street Global Advisors — 0.28%

Asset mix

Asset typeXLVPPH
Stocks99.7%99.5%
Cash & short-term funds0.3%0.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVPPH
US97.9%60.8%
GB—11.8%
CH—10.6%
DK—5.4%
FR—4.0%
IL—3.1%
JP—2.9%
IE2.1%1.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and PPH overlap?
About 43% by weight. 8 securities appear in both funds' top 25 holdings; they make up 47.4% of XLV's assets and 55.5% of PPH's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and PPH have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, AbbVie Inc, Johnson & Johnson, Pfizer Inc.
Should I own both XLV and PPH?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or PPH?
XLV is broader, with 65 positions versus 26 for PPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.